KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Divestments (2016 - 2021)

Historic Divestments for Abbott Laboratories (ABT) over the last 5 years, with Q3 2021 value amounting to $86.0 million.

  • Abbott Laboratories' Divestments changed N/A to $86.0 million in Q3 2021 from the same period last year, while for Dec 2022 it was $86.0 million, marking a year-over-year decrease of 1041.67%. This contributed to the annual value of $1.0 million for FY2024, which is 9750.0% down from last year.
  • Abbott Laboratories' Divestments amounted to $86.0 million in Q3 2021.
  • In the past 5 years, Abbott Laboratories' Divestments registered a high of $5.5 billion during Q1 2017, and its lowest value of -$29.0 million during Q3 2017.
  • Its 3-year average for Divestments is $1.0 billion, with a median of $48.0 million in 2020.
  • Within the past 5 years, the most significant YoY rise in Abbott Laboratories' Divestments was 2178800.0% (2017), while the steepest drop was 2178800.0% (2017).
  • Abbott Laboratories' Divestments (Quarter) stood at $600.0 million in 2017, then tumbled by 98.33% to $10.0 million in 2020, then skyrocketed by 760.0% to $86.0 million in 2021.
  • Its Divestments stands at $86.0 million for Q3 2021, versus $10.0 million for Q4 2020 and $600.0 million for Q4 2017.